TOBI treats Pseudomonas aeruginosa (Pa) infections in people with cystic fibrosis.
Pa infection in the lungs is a major cause of decreased lung function. TOBI® (Tobramycin Inhalation Solution, USP) is made specifically to treat Pa in the lungs. When TOBI is taken using the FDA-approved
nebulizer
and compressor
, it goes into the lungs and reaches the infected areas. This helps decrease the amount of Pa in sputum
and improves lung function.
